BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 11179338)

  • 1. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection.
    Lacroix S; Mancassola R; Naciri M; Laurent F
    Infect Immun; 2001 Mar; 69(3):1635-42. PubMed ID: 11179338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM; Bonafonte MT; Campbell LD; Mead JR
    Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
    Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
    Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice.
    Smith LM; Bonafonte MT; Mead JR
    J Parasitol; 2000 Apr; 86(2):300-7. PubMed ID: 10780549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
    Aguirre SA; Perryman LE; Davis WC; McGuire TC
    J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection.
    Lacroix-Lamandé S; Mancassola R; Naciri M; Laurent F
    Infect Immun; 2002 Apr; 70(4):2090-9. PubMed ID: 11895975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum.
    Jakobi V; Petry F
    Parasite Immunol; 2008 Mar; 30(3):151-61. PubMed ID: 18179628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines.
    McDonald SA; O'Grady JE; Bajaj-Elliott M; Notley CA; Alexander J; Brombacher F; McDonald V
    J Infect Dis; 2004 Sep; 190(5):1019-25. PubMed ID: 15295711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice.
    Ehigiator HN; McNair N; Mead JR
    Exp Parasitol; 2007 Feb; 115(2):107-13. PubMed ID: 16920103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
    Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
    Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
    Müller A; Schott-Ohly P; Dohle C; Gleichmann H
    Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-gamma and interleukin-12-deficient mice to naive recipients.
    Tessema TS; Dauber E; Petry F
    Vaccine; 2009 Nov; 27(47):6575-81. PubMed ID: 19717136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.
    Gazzinelli RT; Eltoum I; Wynn TA; Sher A
    J Immunol; 1993 Oct; 151(7):3672-81. PubMed ID: 7690809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice.
    Ehigiator HN; Romagnoli P; Borgelt K; Fernandez M; McNair N; Secor WE; Mead JR
    Parasite Immunol; 2005; 27(1-2):17-28. PubMed ID: 15813719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
    Salkowski CA; Detore G; McNally R; van Rooijen N; Vogel SN
    J Immunol; 1997 Jan; 158(2):905-12. PubMed ID: 8993010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
    Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
    J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
    Margenthaler JA; Kataoka M; Flye WM
    J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
    Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
    J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon.
    Barakat FM; McDonald V; Foster GR; Tovey MG; Korbel DS
    J Infect Dis; 2009 Nov; 200(10):1548-55. PubMed ID: 19821721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.